Time for our monthly roundup of news stories that highlight key trends for U.S. drug channels. In this issue, get your claws into the following:
- Teva launches an Advair competitor with a gross-to-net bubble busting strategy
- A Diplomat Pharmacy exec gives us a great checklist for assessing specialty pharmacies
- Wow! 60% of oncology practices are now owned by hospitals and health systems
Plus, Starbucks has some exciting news for insulin makers!
P.S. Stay up to date on the news and reports that I find intriguing by following @DrugChannels on Twitter.
Read more »
Source: Post feed
